Earn points on every order New products in stock Free 51-page beginner’s guide
← Back to Compound Library

TESTOSTERONE CYPIONATE

Injectable testosterone with a long “ester” so it releases over ~8 days. The foundation of TRT and most steroid cycles. This is an anabolic-androgenic steroid, an oil, not a peptide; with a different and more serious risk profile (it shuts down your own testosterone, thickens blood, and worsens cholesterol).

Research referenceCommunity compiled

Molecular profile

The molecule itself: sequence, composition, mass, target, and registry identifiers.

Molecular formula
C₂₇H₄₀O₃
Average mass
412.6 Da
CAS number
58-20-8
Registry
PubChem CID 441404
Receptor / pathway
Androgen receptor
Formula, mass and identifiers from PubChem CID 441404.
Research & reference information

This profile compiles research and community-sourced reference information for educational purposes. Information may evolve as research and community knowledge develop. It is not individualized medical advice.

Overview

Testosterone Cypionate is a long-acting esterified form of the primary male androgenic and anabolic hormone, testosterone.

What problem it targets: It targets primary and secondary male hypogonadism (low testosterone), chronic fatigue, loss of muscle mass, stubborn body fat gain, low libido, and brain fog.

What It Does

• Restores physiological androgen levels: Binds androgen receptors in muscle, bone, brain, and fat tissues, restoring youthful male biological signaling.

• Accelerates protein synthesis and muscle growth: Increases cellular nitrogen retention and accelerates muscle hypertrophy while increasing red blood cell count for oxygen delivery.

• Supports bone density and mental vitality: Maintains skeletal mineral density and elevates mood, drive, and sexual performance through central dopamine and neurosteroid signaling.

• Realistic expectations: Administered via intramuscular or subcutaneous injection once or twice weekly (half-life ~8 days). Energy and libido return in 2 to 4 weeks; muscle and fat changes mature over 3 to 6 months.

Presentation

VialFormConcentrationNote
10 mLOil solution (no reconstitution)250 mg/mL0.1 mL = 25 mg. Draw with a larger-gauge needle, inject with a smaller one.

Protocol

UseFrequencyDoseVolume (250 mg/mL)Notes
TRT2×/week (split)100–150 mg/week0.2–0.3 mL ×2Replacement dosing. Split doses smooth levels and estrogen.
Cycle (enhancement)2×/week300–600 mg/week0.6–1.2 mL ×2Supraphysiologic, risk rises with dose. 12–16 weeks typical, then PCT. Cycle: TRT is continuous (lifelong, with monitoring); enhancement cycles run 12–16 weeks then either PCT (restart) or cruise. Estrogen: aromatizes, an aromatase inhibitor may be needed at higher doses (don’t crush estrogen to zero). Note: controlled substance; HPTA suppression means you need a plan to recover or stay on. Women: Testosterone is the primary male androgen; women need only trace amounts. Male-range doses cause virilization, voice deepening, facial/body hair, clitoral enlargement, male-pattern balding; much of it permanent. Not appropriate at the doses on this page. Men: Standard TRT/cycle compound. Suppresses natural production & sperm; aromatizes to estrogen. Monitor hematocrit, estradiol, PSA, lipids; add hCG to preserve fertility.

Handling & Stacking

Injection site
IM (glute/quad/delt) or SubQ. Rotate. Sterile technique.
Storage
Room temp, dark. Oil may cloud if cold, warm to clear. Single-use draws.
Side effects
Acne, oily skin, hair loss (if predisposed), water retention, estrogen rise (gyno), testicular shrinkage, mood changes, elevated hematocrit, lipid worsening.
What to expect
  • Improved libido, energy, muscle, and recovery.
  • Suppression of natural production.
  • Effects and side effects scale with dose.
  • Supply math 10mL → ~16 weeks at TRT (150 mg/wk) | ~5 weeks at 500 mg/wk cycle
Pairs well with
HCG (preserve testicular function/fertility on cycle); an AI if estrogen climbs. Base of most stacks (e.g. with EQ)
Avoid
Prostate or breast cancer. High red-blood-cell count (high hematocrit). Untreated sleep apnea. Pregnancy exposure (partner). Uncontrolled heart disease

Safety & Patient Education

Contraindications
Prostate cancer or breast cancer in men Polycythemia / high hematocrit Untreated severe sleep apnea, severe uncontrolled heart failure Pregnancy (teratogenic exposure risk to a partner)
Warnings
HPTA suppression, testicular atrophy and infertility; recovery not guaranteed after long/high use High red-blood-cell count (thick blood), clot/stroke risk; may need donation/dose reduction Adverse lipid changes (HDL drop) and cardiovascular risk Estrogen-related gynecomastia / water retention; mood and aggression changes Worsens benign prostate symptoms; accelerates male-pattern hair loss if predisposed
Drug interactions
Anticoagulants: testosterone can potentiate warfarin, monitor INR Insulin/antidiabetics: improved insulin sensitivity may lower needs Other 17-alpha-alkylated orals: additive hepatic/lipid strain
Labs
  • Baseline + periodic: total/free testosterone, estradiol, CBC (hematocrit), lipid panel, PSA (age-appropriate), liver enzymes Blood pressure each visit Out of range?
  • Hematocrit >54% = blood too thick (donate or hold); high estradiol = manage it; a rising PSA = get the prostate checked.
Stop criteria
Hematocrit >54% (or per clinician) Chest pain, severe headache, vision/neurologic changes (clot/stroke signs) New breast lumps, severe mood disturbance Rising PSA / prostate concerns
Patient education
This is a controlled anabolic steroid, not a peptide; manage it with bloodwork It shuts down your own production, have a plan (PCT or stay-on) Watch hematocrit, estrogen, lipids, and blood pressure Higher doses = proportionally higher risk; don’t crush estrogen to zero
References
rxlist · dailymed · researchdosing